148 related articles for article (PubMed ID: 8261461)
1. Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls.
Schultz DC; Bazel S; Wright LM; Tucker S; Lange MK; Tachovsky T; Longo S; Niedbala S; Alhadeff JA
Cancer Res; 1994 Jan; 54(1):48-54. PubMed ID: 8261461
[TBL] [Abstract][Full Text] [Related]
2. Characterization of purified cathepsin D from malignant human breast tissue.
Bazel S; Alhadeff JA
Int J Oncol; 1999 Feb; 14(2):315-9. PubMed ID: 9917508
[TBL] [Abstract][Full Text] [Related]
3. Correlation between mannose-6-phosphate/IGFII receptor and cathepsin D RNA levels by in situ hybridization in benign and malignant mammary tumors.
Zhao Y; Escot C; Maudelonde T; Puech C; Rouanet P; Rochefort H
Cancer Res; 1993 Jun; 53(12):2901-5. PubMed ID: 7684951
[TBL] [Abstract][Full Text] [Related]
4. Monocyte tissue factor levels in cancer patients.
Lwaleed BA; Francis JL; Chisholm M
Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients.
Foekens JA; Look MP; Bolt-de Vries J; Meijer-van Gelder ME; van Putten WL; Klijn JG
Br J Cancer; 1999 Jan; 79(2):300-7. PubMed ID: 9888472
[TBL] [Abstract][Full Text] [Related]
6. Western blotting and isoform analysis of cathepsin D from normal and malignant human breast cell lines.
Laury-Kleintop LD; Coronel EC; Lange MK; Tachovsky T; Longo S; Tucker S; Alhadeff JA
Breast Cancer Res Treat; 1995 Aug; 35(2):211-20. PubMed ID: 7647343
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.
Ioachim EE; Athanassiadou SE; Kamina S; Carassavoglou K; Agnantis NJ
Anticancer Res; 1998; 18(3A):1665-70. PubMed ID: 9673387
[TBL] [Abstract][Full Text] [Related]
8. Tumour epidermal growth factor receptor, erbB-2 and cathepsin D in node-negative invasive breast cancer: their impact on the selection of patients for systemic adjuvant therapy.
Tonkin KS; McKay JW; Stitt LW; Tokmakejian S; Haines DS
Cancer Prev Control; 1999 Apr; 3(2):131-6. PubMed ID: 10474760
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin D and dynamic magnetic resonance imaging gadolinium enhancement in malignant and benign breast lesions.
Stomper PC; Winston JS; Herman S; Klippenstein DL; Blumenson LE
Clin Cancer Res; 1997 Apr; 3(4):559-63. PubMed ID: 9815720
[TBL] [Abstract][Full Text] [Related]
10. Tissue and serum c-erbB-2 and tissue EGFR in breast carcinoma: three years follow-up.
Mansour OA; Zekri AR; Harvey J; Teramoto Y; el-Ahmady O
Anticancer Res; 1997; 17(4B):3101-6. PubMed ID: 9329611
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
13. Characterization and properties of two monoclonal antibodies specific for the Mr 52,000 precursor of cathepsin D in human breast cancer cells.
Freiss G; Vignon F; Rochefort H
Cancer Res; 1988 Jul; 48(13):3709-15. PubMed ID: 2454153
[TBL] [Abstract][Full Text] [Related]
14. Cytosol cathepsin D in Thai women with breast cancer.
Chearskul S; Bhothisuwan K; Tunsuphasiri V; Churinthrapun M; Keyanond V; Ornrheabroi S
J Med Assoc Thai; 1996 Oct; 79(10):654-60. PubMed ID: 8997001
[TBL] [Abstract][Full Text] [Related]
15. Human breast milk contains procathepsin D--detection by specific antibodies.
Vĕtvicka V; Vágner J; Baudys M; Tang J; Foundling SI; Fusek M
Biochem Mol Biol Int; 1993 Aug; 30(5):921-8. PubMed ID: 8220241
[TBL] [Abstract][Full Text] [Related]
16. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
17. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma VM; Savolainen K; Uusitupa M; Mononen I
Br J Cancer; 1999 Mar; 79(9-10):1583-7. PubMed ID: 10188910
[TBL] [Abstract][Full Text] [Related]
18. Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay.
Brouillet JP; Dufour F; Lemamy G; Garcia M; Schlup N; Grenier J; Mani JC; Rochefort H
Cancer; 1997 Jun; 79(11):2132-6. PubMed ID: 9179059
[TBL] [Abstract][Full Text] [Related]
19. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
Rochefort H
C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
[TBL] [Abstract][Full Text] [Related]
20. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
